6,700 Shares in Danaher Corporation $DHR Acquired by Intact Investment Management Inc.

Intact Investment Management Inc. acquired a new stake in shares of Danaher Corporation (NYSE:DHR) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 6,700 shares of the conglomerate’s stock, valued at approximately $1,328,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. WFA of San Diego LLC purchased a new stake in Danaher in the second quarter valued at $26,000. Howard Hughes Medical Institute purchased a new stake in shares of Danaher in the second quarter worth about $27,000. TruNorth Capital Management LLC acquired a new stake in Danaher during the third quarter worth about $28,000. Red Tortoise LLC raised its position in Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after acquiring an additional 98 shares in the last quarter. Finally, Tripletail Wealth Management LLC acquired a new position in Danaher in the third quarter valued at approximately $31,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 0.7%

NYSE:DHR opened at $236.70 on Tuesday. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The stock’s fifty day moving average is $230.59 and its two-hundred day moving average is $213.48. The stock has a market capitalization of $167.19 billion, a price-to-earnings ratio of 48.80, a price-to-earnings-growth ratio of 3.58 and a beta of 0.89. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.5%. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on DHR. Evercore ISI reaffirmed an “outperform” rating and issued a $250.00 price target on shares of Danaher in a report on Monday, January 5th. TD Cowen reaffirmed a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. Rothschild & Co Redburn reissued a “neutral” rating and issued a $220.00 price target (down previously from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Argus set a $265.00 price objective on shares of Danaher in a research report on Wednesday, January 14th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Twenty research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $252.09.

Insider Activity at Danaher

In related news, SVP Georgeann Couchara sold 5,174 shares of the company’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the sale, the senior vice president directly owned 2,625 shares of the company’s stock, valued at $552,352.50. This represents a 66.34% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Teri List sold 3,298 shares of the firm’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the transaction, the director directly owned 20,762 shares of the company’s stock, valued at $4,702,593. This represents a 13.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 30,248 shares of company stock worth $6,609,663. Corporate insiders own 11.20% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.